Health Trials

About this trial

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Eligibility criteria

Qualifiers

Have been diagnosed with chronic CS according to the ESC guidelines;

Over 18 years of age;

Patients admitted to hospital or with access to first aid within the last year;

Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);

Disqualifiers

Severe psychiatric disorder

Inability to use portable technologies

Patients unable to use the equipment provided

Patients who deny consent to study participation

Trial design

Treatments tested in this trial

  • Telemonitoring app

Treatment groups

184 Participants
are divided into 2 treatment groups

Locations

1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico20122, MilanItaly, Italy

Sponsors and collaborators

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Lead sponsor

ASST Grande Ospedale Metropolitano Niguarda

Collaborator

University of Milan

Collaborator

Source ClinicalTrials.gov